{
  "primary": "SUMO1",
  "interaction_type": "direct",
  "upstream_interactor": null,
  "mediator_chain": [],
  "depth": 1,
  "support_summary": "ATXN3 is covalently modified by Small Ubiquitin-like Modifier 1 (SUMO1) in a process called SUMOylation. This direct modification, primarily at lysine 166, enhances the stability of polyQ-expanded ATXN3 by preventing its degradation, which contributes to its cytotoxicity.",
  "functions": [
    {
      "function": "ATXN3 SUMOylation",
      "arrow": "activates",
      "cellular_process": "ATXN3 is post-translationally modified by the covalent attachment of SUMO1. This process is catalyzed by a cascade of E1, E2 (UBC9), and E3 (e.g., PIAS1) enzymes and primarily targets lysine 166 within ATXN3.",
      "effect_description": "SUMOylation of ATXN3 enhances its protein stability by competing with ubiquitination, thereby preventing its degradation by the proteasome and increasing its cytotoxic potential.",
      "biological_consequence": [
        "SUMO1 is covalently attached to ATXN3 at lysine 166 → SUMOylation competes with ubiquitination → Reduced proteasomal degradation of ATXN3 → Increased stability of mutant ATXN3 protein → Enhanced ATXN3-mediated apoptosis"
      ],
      "specific_effects": [
        "SUMO-1 modification occurs at lysine 166 of polyQ-expanded ataxin-3.",
        "SUMOylation increases the stability of mutant ataxin-3.",
        "Increased stability of SUMOylated ATXN3 leads to increased cell apoptosis.",
        "SUMOylation does not influence the subcellular localization or aggregation of mutant ataxin-3."
      ],
      "evidence": [
        {
          "paper_title": "SUMO-1 modification on K166 of polyQ-expanded ataxin-3 strengthens its stability and increases its cytotoxicity",
          "doi": "10.1371/journal.pone.0054214",
          "authors": "Zhou YF, Wang Y, Li Y, Jiang H, Gong L, Zhou L, Chen C, Chen Y, Tang BS, Shen L",
          "journal": "PLoS One",
          "year": 2013,
          "assay": "Co-Immunoprecipitation, In vitro SUMOylation assay",
          "species": "human",
          "relevant_quote": "Here we identified that the major SUMO-1 binding site was located on lysine 166. SUMOylation...partially increased its stability and the cell apoptosis.",
          "pmid": "23382880"
        }
      ],
      "pmids": [
        "23382880"
      ],
      "interaction_effect": "activates",
      "interaction_direction": "primary_to_main",
      "function_effect": "activation"
    }
  ],
  "arrow": "binds",
  "direction": "primary_to_main",
  "intent": "sumoylation",
  "arrows": {
    "primary_to_main": [
      "activates"
    ]
  },
  "mechanism": "ATXN3 is post-translationally modified by the covalent attachment of SUMO1. This process is catalyzed by a cascade of E1, E2 (UBC9), and E3 (e.g., PIAS1) enzymes and primarily targets lysine 166 within ATXN3.",
  "effect": "SUMOylation of ATXN3 enhances its protein stability by competing with ubiquitination, thereby preventing its degradation by the proteasome and increasing its cytotoxic potential.",
  "summary": "ATXN3 activates SUMO1 to modulate atxn3 sumoylation, ultimately affecting enhanced atxn3-mediated apoptosis.",
  "evidence": [
    {
      "paper_title": "SUMO-1 modification on K166 of polyQ-expanded ataxin-3 strengthens its stability and increases its cytotoxicity",
      "doi": "10.1371/journal.pone.0054214",
      "authors": "Zhou YF, Wang Y, Li Y, Jiang H, Gong L, Zhou L, Chen C, Chen Y, Tang BS, Shen L",
      "journal": "PLoS One",
      "year": 2013,
      "assay": "Co-Immunoprecipitation, In vitro SUMOylation assay",
      "species": "human",
      "relevant_quote": "Here we identified that the major SUMO-1 binding site was located on lysine 166. SUMOylation...partially increased its stability and the cell apoptosis."
    },
    {
      "paper_title": "Covalent modification of ataxin-3 by SUMO-1",
      "doi": "10.1016/j.neulet.2008.08.051",
      "authors": "Li Y, Zhou L, Wang Y, Chen C, Chen Y, Jiang H, Gong L, Tang B, Shen L",
      "journal": "Neuroscience Letters",
      "year": 2008,
      "assay": "Yeast two-hybrid, Co-Immunoprecipitation",
      "species": "human",
      "relevant_quote": "Small ubiquitin-like modifier 1(SUMO-1) was identified as a novel ataxin-3-interacting protein...both the wild-type ataxin-3 and the polyglutamine-expanded ataxin-3 were covalently modified by SUMO-1"
    }
  ],
  "interaction_effect": "binding",
  "_validation_metadata": {
    "validated": true,
    "validator": "arrow_effect_validator",
    "corrections_applied": 2
  },
  "_arrow_validated": true,
  "arrow_notation": "ATXN3 <--binds-- SUMO1:",
  "protein_a": "ATXN3",
  "protein_b": "SUMO1",
  "discovered_in_query": "ATXN3",
  "first_discovered": "2025-11-23T07:58:56.227774Z",
  "last_updated": "2025-11-23T07:58:56.227774Z"
}